Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPISO
2024-516074-29-01Phase 3Authorised
- Sponsor
- University Hospital Odense
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of isoprenaline in cardiac arrest (SCA) (2 arms), sponsored by University Hospital Odense. Primary endpoint: Sustained return of spontaneous circulation of at least 20 minutes. Planned start Aug 2025; status: authorised.
02
Drugs
isoprenaline
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on 2024-516074-29-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516074-29-01.